Absci Company

Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Technology: Anti-infective Drugs
Industry: Early Drug Development
Headquarters: Vancouver, Washington, United States
Founded Date: 2011-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 23
Total Funding: 237859989
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-03-23
Last Funding Type: Venture - Series Unknown

Visit Website
info@absci.com
https://twitter.com/abscibio
Register and Claim Ownership